Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study

Authors

Institutions

Publication Details

Journal
ESMO Open
Published
2025-11-25
DOI
https://doi.org/10.1016/j.esmoop.2025.105869
Citations
1
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study

Erika Hamilton, Alexandre Seiller, Yanqiu Feng, Sherko Küemmel et al.
1 citations
ESMO Open
HER2/EGFR in Cancer Research
1.05
article

Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study

Erika Hamilton, Alexandre Seiller, Yanqiu Feng, Sherko Küemmel, Luis de la Cruz‐Merino, Roberto Hegg, Laise Rodrigues de Andrade, Begoña Bermejo, Ruffo Freitas‐Júnior, Max Dieterich, Kyung Hae Jung, Aneta Swat, Daniele Xavier Assad, Hilary Martin, Andreas Schneeweiß, Ran Meng, Anh Nguyen Duc, C.-S. Huang
article en
1 citations

Abstract

No abstract available for this paper.
ESMO OpenVol. 10(12)
Ulsan College (KR), Roche (Switzerland) (CH), Asan Medical Center (KR), University of Ulsan (KR), Sarah Cannon (US), D’Or Institute for Research and Education (BR), National Taiwan University Hospital (TW), Hospital da Mulher São Paulo (BR), Hospital Sírio-Libanês (BR), Universidade Federal de Goiás (BR)
Openalex Percentile: Top 15%
HER2/EGFR in Cancer Research
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study — Erika Hamilton, Alexandre Seiller, et al. · ESMO Open (2025) | TGRS Research Map | TGRS